Tazemetostat for the treatment of INI-1-deficient sinonasal tumor
- PMID: 35820243
- DOI: 10.1016/j.ejca.2022.06.032
Tazemetostat for the treatment of INI-1-deficient sinonasal tumor
Conflict of interest statement
Conflict of interest statement The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
